Corporate News     03-Mar-23
Caplin Steriles receives USFDA approval for Rocuronium Bromide Injection
Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories , has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Rocuronium Bromide Injection, 10 mg/mL in 5 mL and 10 mL Multi-dose Vials, a generic therapeutic equivalent version of (RLD), ZEMURON Injection, of Organon USA Inc.

Rocuronium Bromide Injection is a neuromuscular blocking agent, indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. According to IQVIATM (IMS Health), Rocuronium Bromide Injection had US sales of approximately $53 million for the 12-month period ending September 2022.

Previous News
  Caplin Point gains after receiving EIR report from USFDA for Tamil Nadu facility
 ( Hot Pursuit - 07-Jan-25   14:45 )
  Caplin Point Laboratories to hold board meeting
 ( Corporate News - 01-Feb-25   10:02 )
  Board of Caplin Point Laboratories recommends Interim Dividend
 ( Corporate News - 16-May-24   14:24 )
  Caplin Point Laboratories receives INVIMA approval for Softgel Capsules division at Puducherry
 ( Corporate News - 06-May-24   14:53 )
  Caplin Point Laboratories fixes record date for final dividend
 ( Market Beat - Reports 07-Aug-24   13:17 )
  Caplin Point Laboratories consolidated net profit rises 19.08% in the March 2024 quarter
 ( Results - Announcements 16-May-24   15:05 )
  Caplin Point Laboratories consolidated net profit rises 30.06% in the December 2022 quarter
 ( Results - Announcements 11-Feb-23   15:15 )
  Indices trade with major gains; pharma shares in demand
 ( Market Commentary - Mid-Session 07-Aug-24   14:33 )
  Caplin Point rallies after Q1 PAT climbs 20% YoY to Rs 125 cr
 ( Hot Pursuit - 07-Aug-24   13:23 )
  Caplin Point Laboratories allots 91,704 equity shares under ESOP
 ( Corporate News - 15-Dec-22   12:51 )
  Caplin Point arm commences operations at Oncology facility in Chennai
 ( Hot Pursuit - 27-Mar-24   13:47 )
Other Stories
  Titagarh Rail Systems receives order worth Rs 537.11 cr
  12-Feb-25   14:50
  Suzlon Group secures repeat order of 201.06 MW from Oyster Renewable
  12-Feb-25   13:56
  Board of Hindustan Aeronautics recommends First Interim Dividend
  12-Feb-25   13:53
  Board of Power Finance Corporation recommends Third Interim Dividend
  12-Feb-25   13:53
  Carborundum Universal to announce Quarterly Result
  12-Feb-25   11:36
  Northlink Fiscal and Capital Serv. schedules board meeting
  12-Feb-25   11:36
  SecMark Consultancy to conduct board meeting
  12-Feb-25   11:36
  SBI Cards & Payment Services schedules board meeting
  12-Feb-25   11:36
  GEE to announce Quarterly Result
  12-Feb-25   11:35
  Heera Ispat to convene board meeting
  12-Feb-25   11:35
Back Top